Cargando…
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
IBD, a chronic inflammatory disease, has been manifested as a growing health problem. No Crohn’s and Colitis councils have officially ratified anti-depressants as a routine regimen for IBD patients. However, some physicians empirically prescribe them to rectify functional bowel consequences such as...
Autores principales: | Hatamnejad, Mohammad Reza, Baradaran Ghavami, Shaghayegh, Shirvani, Marzieh, Asghari Ahmadabad, Mona, Shahrokh, Shabnam, Farmani, Maryam, Sherkat, Ghazal, Asadzadeh Aghdaei, Hamid, Zali, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583131/ https://www.ncbi.nlm.nih.gov/pubmed/36275739 http://dx.doi.org/10.3389/fimmu.2022.980189 |
Ejemplares similares
-
Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs)
por: Khoramjoo, Seyed Mobin, et al.
Publicado: (2022) -
Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2022) -
Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020) -
Association between variants of the autophagy related gene ATG16L1 in inflammatory bowel diseases and clinical statues
por: Baradaran Ghavami, Shaghayegh, et al.
Publicado: (2019) -
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
por: Baradaran Ghavami, Shaghayegh, et al.
Publicado: (2021)